Anaphylaxie

• Literatur

• 1 Worm M, Eckermann O, Dölle S. et al. Auslöser und Therapie der Anaphylaxie: Auswertung von mehr als 4000 Fällen aus Deutschland, Österreich und der Schweiz. Dtsch Arztebl International 2014; 111: 367-375
• 2 Lenzen-Schulte M. Notfallhilfe bei allergischem Schock (15.06.2014). Im Internet: http://www.faz.net/aktuell/wissen/medizin/behandlungsfehler-notfallhilfe-bei-allergischem-schock-12980884.html Stand: 25.11.2014
• 3 Simons FE, Ardusso LR, Bilo MB. et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014; 7: 9
• 4 Ring J BK, Biedermann T, Bircher A. et al. Guideline for acute therapy and management of anaphylaxis – S2 Guideline of DGAKI, AeDA, GPA, DAAU, BVKJ, ÖGAI, SGAI, DGAI, DGP, DGPM, AGATE and DAAB. Allergo J Int 2014; 23: 96-112
• 5 Muraro A, Halken S, Arshad SH. et al. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy 2014; 69: 590-601
• 6 Worm M. Epidemiology of anaphylaxis. Hautarzt 2013; 64: 88-92
• 7 Khan BQ, Kemp SF. Pathophysiology of anaphylaxis. Curr Opin Allergy Clin Immunol 2011; 11: 319-325
• 8 De Bisschop MB, Bellou A. Anaphylaxis. Curr Opin Crit Care 2012; 18: 308-317
• 9 Finkelman FD. Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 2007; 120: 506-515 quiz 516–517
• 10 Vadas P, Gold M, Perelman B. et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008; 358: 28-35
• 11 Barbara DW, Ronan KP, Maddox DE. et al. Perioperative angioedema: background, diagnosis, and management. J Clin Anesth 2013; 25: 335-343
• 12 Han L, Dong X. Itch mechanisms and circuits. Annu Rev Biophys 2014; 43: 331-355
• 13 Walther A, Bottiger BW. Out-of-Hospital treatment of anaphylactoid reactions. Internist (Berl) 2004; 45: 296-304
• 14 Genovese A, Rossi FW, Spadaro G. et al. Human cardiac mast cells in anaphylaxis. Chem Immunol Allergy 2010; 95: 98-109
• 15 Mazarakis A, Bardousis K, Almpanis G. et al. Kounis syndrome following cold urticaria: The swimmerʼs death. Int J Cardiol 2014; 176: e52-e53
• 16 Kounis NG. Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm?. Int J Cardiol 2006; 110: 7-14
• 17 Triggiani M, Montagni M, Parente R. et al. Anaphylaxis and cardiovascular diseases: a dangerous liaison. Curr Opin Allergy Clin Immunol 2014; 14: 309-315
• 18 Morel O, Jesel L, Morel N. et al. Transient left ventricular dysfunction syndrome during anaphylactic shock: vasospasm, Kounis syndrome or epinephrine-induced stunned myocardium?. Int J Cardiol 2010; 145: 501-503
• 19 Fassio F, Almerigogna F. Kounis syndrome (allergic acute coronary syndrome): different views in allergologic and cardiologic literature. Intern Emerg Med 2012; 7: 489-495
• 20 Montrucchio G, Alloatti G, Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 2000; 80: 1669-1699
• 21 Oschatz C, Maas C, Lecher B. et al. Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity 2011; 34: 258-268
• 22 Sala-Cunill A, Björkqvist J, Senter R. et al. Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions. J Allergy Clin Immunol 2014;
• 23 Simons FE. H1-Antihistamines: more relevant than ever in the treatment of allergic disorders. J Allergy Clin Immunol 2003; 112: S42-S52
• 24 Evora PR, Simon MR. Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue. Ann Allergy Asthma Immunol 2007; 99: 306-313
• 25 Cauwels A, Janssen B, Buys E. et al. Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest 2006; 116: 2244-2251
• 26 Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med 2012; 18: 693-704
• 27 Burton OT, Darling AR, Zhou JS. et al. Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy. Mucosal Immunol 2013; 6: 740-750
• 28 Worm M, Edenharter G, Rueff F. et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012; 67: 691-698
• 29 Timmermann A, Byhahn C, Wenzel V. Handlungsempfehlung für das präklinische Atemwegsmanagement. Für Notärzte und Rettungsdienstpersonal. Anästh Intensivmed 2012; 53: 294-308
• 30 Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 2005; 22: 272-273
• 31 Kemp AM, Kemp SF. Pharmacotherapy in refractory anaphylaxis: when intramuscular epinephrine fails. Curr Opin Allergy Clin Immunol 2014; 14: 371-378
• 32 Kemp SF. The post-anaphylaxis dilemma: how long is long enough to observe a patient after resolution of symptoms?. Curr Allergy Asthma Rep 2008; 8: 45-48